These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25604143)

  • 41. Association between human urotensin II and essential hypertension--a 1:1 matched case-control study.
    Peng H; Zhang M; Cai X; Olofindayo J; Tan A; Zhang Y
    PLoS One; 2013; 8(12):e81764. PubMed ID: 24339964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ser326Cys polymorphism in DNA repair genes hOGG1 in breast cancer women.
    Romanowicz-Makowska H; Smolarz B; Makowski M; Połać I; Pertyński T
    Pol J Pathol; 2008; 59(4):201-4. PubMed ID: 19391486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
    Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M
    J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma urotensin II in heart failure.
    Richards AM; Nicholls MG; Lainchbury JG; Fisher S; Yandle TG
    Lancet; 2002 Aug; 360(9332):545-6. PubMed ID: 12241661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
    Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
    Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.
    Chou YC; Wu MH; Yu JC; Lee MS; Yang T; Shih HL; Wu TY; Sun CA
    Carcinogenesis; 2006 Nov; 27(11):2295-300. PubMed ID: 16777985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum urotensin II levels in patients with non-dipper hypertension.
    Erbay AR; Meric M; Alacam H; Zengin H; Akin F; Okuyucu A; Yuksel S; Soylu K; Gedikli O
    Clin Exp Hypertens; 2013; 35(7):506-11. PubMed ID: 23301552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors.
    Federico A; Zappavigna S; Dallio M; Misso G; Merlino F; Loguercio C; Novellino E; Grieco P; Caraglia M
    Curr Cancer Drug Targets; 2017; 17(2):109-121. PubMed ID: 27338741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation on the role of XPG gene polymorphisms in breast cancer risk in a Chinese population.
    Ma SH; Ling FH; Sun YX; Chen SF; Li Z
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.
    Hirose T; Takahashi K; Mori N; Nakayama T; Kikuya M; Ohkubo T; Kohzuki M; Totsune K; Imai Y
    Peptides; 2009 Jun; 30(6):1124-9. PubMed ID: 19463745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inflammatory breast cancer: High incidence of GCC haplotypes (-1082A/G, -819T/C, and -592A/C) in the interleukin-10 gene promoter correlates with over-expression of interleukin-10 in patients' carcinoma tissues.
    Sabet S; El-Sayed SK; Mohamed HT; El-Shinawi M; Mohamed MM
    Tumour Biol; 2017 Jul; 39(7):1010428317713393. PubMed ID: 28675120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The differential extraction and immunoluminometric assay of Urotensin II and Urotensin-related peptide in heart failure.
    Jani PP; Narayan H; Ng LL
    Peptides; 2013 Feb; 40():72-6. PubMed ID: 23270674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of two competitive enzyme immunoassay kits for quantification of plasma Urotensin-II in rats.
    Rodríguez-Rodríguez A; Egea-Guerrero JJ; Vilches-Arenas Á; Quintanilla-Vázquez MJ; Murillo-Cabezas F; Muñoz-Sánchez MÁ
    J Immunoassay Immunochem; 2017; 38(3):247-256. PubMed ID: 27801612
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased plasma urotensin II levels in patients with diabetes mellitus.
    Totsune K; Takahashi K; Arihara Z; Sone M; Ito S; Murakami O
    Clin Sci (Lond); 2003 Jan; 104(1):1-5. PubMed ID: 12519081
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of the MTHFR Gene C677T Polymorphism with Breast Cancer in a Turkish Population.
    Kaya EF; Karakus N; Ulusoy AN; Özaslan C; Kara N
    Oncol Res Treat; 2016; 39(9):534-8. PubMed ID: 27614738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Urotensin II--a newly discovered modulator of cardiovascular functions in vertebrates].
    Zemancíková A; Török J
    Cesk Fysiol; 2013; 62(1):19-25. PubMed ID: 23821959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor necrosis factor alpha and beta and interferon gamma gene polymorphisms in Turkish breast cancer patients.
    Karakus N; Kara N; Ulusoy AN; Ozaslan C; Bek Y
    DNA Cell Biol; 2011 Jun; 30(6):371-7. PubMed ID: 21323572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients.
    Shi Q; Wang LE; Bondy ML; Brewster A; Singletary SE; Wei Q
    Carcinogenesis; 2004 Sep; 25(9):1695-700. PubMed ID: 15090466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.